Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel W. McNeil is active.

Publication


Featured researches published by Daniel W. McNeil.


Tetrahedron Letters | 1990

Spiro indolinone beta-lactams, inhibitors of poliovirus and rhinovlrus 3C-proteinases

Jerry W. Skiles; Daniel W. McNeil

Preparation of the spiro beta-lactam 7 and its evaluation as a poliovirus and human rhinovirus 3C-proteinase inhibitor is described.


Bioorganic & Medicinal Chemistry Letters | 2003

Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK).

Charles L. Cywin; Bao-Ping Zhao; Daniel W. McNeil; Matt Hrapchak; Anthony S. Prokopowicz; Daniel R. Goldberg; Tina Marie Morwick; Amy Gao; Scott Jakes; Mohammed A. Kashem; Ronald L. Magolda; Richard Soll; Mark R. Player; Mark A. Bobko; James M. Rinker; Renee L. DesJarlais; Michael P. Winters

The discovery of novel 5,7-disubstituted[1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK) is discussed. The SAR reveals the necessity for a 7-aryl group with preference towards para substitution and that this in combination with 5-aminoalkylamino substituents further improved the potency of the compounds. The initial SAR as well as a survey of the other positions is discussed in detail.


Tetrahedron Letters | 1994

A simple method for the protection of aryl amines as their t-butylcarbamoyl (Boc) derivatives

Terence A. Kelly; Daniel W. McNeil

It has been found that aryl amines can be directly protected as their Boc derivatives by treatment of the amine with two equivalents of NaHMDS in THF followed by one equivalent of di-t-butyldicarbonate. This procedure works on a wide variety of both electron-rich and electron-deficient aryl amines.


Bioorganic & Medicinal Chemistry Letters | 1993

elastase inhibitors containing conformationally restricted lactams as P3-P2 dipeptide replacements

Jerry W. Skiles; Ronald John Sorcek; Stephen P. Jacober; Clara K. Miao; Philip W. Mui; Daniel W. McNeil; Alan S. Rosenthal

The synthesis of potential human leukocyte elastase (HLE) inhibitors containing conformationally restricted lactams as peptidomimetic replacements at P3-P2 and which contain a trifluoromethyl ketone of valine at P1 are described.


Bioorganic & Medicinal Chemistry | 2003

The design of potent hydrazones and disulfides as cathepsin S inhibitors.

Charles L. Cywin; Raymond A. Firestone; Daniel W. McNeil; Christine A. Grygon; Kathryn M Crane; Della White; Peter R Kinkade; Jerry L. Hopkins; Walter Davidson; Mark E. Labadia; Jessi Wildeson; Maurice M. Morelock; Jeffrey D Peterson; Ernest L. Raymond; Maryanne L. Brown; Denice M. Spero

The design and synthesis of dipeptidyl disulfides and dipeptidyl benzoylhydrazones as selective inhibitors of the cysteine protease Cathepsin S are described. These inhibitors were expected to form a slowly reversible covalent adduct of the active site cysteine of Cathepsin S. Formation of the initial adduct was confirmed by mass spectral analysis. The nature and mechanism of these adducts was explored. Kinetic analysis of the benzoyl hydrazones indicate that these inhibitors are acting as irreversible inhibitors of Cathepsin S. Additionally, the benzoylhydrazones were shown to be potent inhibitors of Cathepsin S processing of Class II associated invariant peptide both in vitro and in vivo.


Journal of Medicinal Chemistry | 1991

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones.

Karl D. Hargrave; John R. Proudfoot; Karl G. Grozinger; Ernest Cullen; Suresh R. Kapadia; Usha R. Patel; Victor Fuchs; Scott C. Mauldin; Jana Vitous; Mark L. Behnke; Janice M. Klunder; Kollol Pal; Jerry W. Skiles; Daniel W. McNeil; Janice M. Rose; Grace C. Chow; Mark T. Skoog; Joe C. Wu; Gunther Schmidt; Wolfhard Engel; Wolfgang Eberlein; Tracy D. Saboe; Scot Campbell; Alan S. Rosenthal; Julian Adams


Journal of Immunology | 1999

Cutting Edge: A Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion

Terence A. Kelly; Deborah D. Jeanfavre; Daniel W. McNeil; Joseph R. Woska; Patricia L. Reilly; Elizabeth Mainolfi; Karen M. Kishimoto; Gerald H. Nabozny; Rosemarie Zinter; Barbara-Jean Bormann; Robert Rothlein


Journal of Medicinal Chemistry | 1992

Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones.

Janice M. Klunder; Karl D. Hargrave; West M; Ernest Cullen; Kollol Pal; Mark L. Behnke; Kapadia; Daniel W. McNeil; Joe C. Wu; Grace C. Chow


Journal of Medicinal Chemistry | 1997

Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.

Edward S. Lazer; Clara K. Miao; Charles L. Cywin; Ronald John Sorcek; Hin-Chor Wong; Zhaoxing Meng; Ian Potocki; Maryann Hoermann; Roger J. Snow; Matt Aaron Tschantz; Terence A. Kelly; Daniel W. McNeil; Simon J. Coutts; Laurie Churchill; Anne G. Graham; Eva David; Peter M. Grob; Wolfhard Engel; Hans Meier; Gunter Trummlitz


Journal of Medicinal Chemistry | 2002

Design and synthesis of dipeptide nitriles as reversible and potent Cathepsin S inhibitors

Yancey David Ward; David S. Thomson; Leah L. Frye; Charles L. Cywin; Tina Morwick; Michel J. Emmanuel; Renee M. Zindell; Daniel W. McNeil; Younes Bekkali; Marc Giradot; Matt Hrapchak; Molly Deturi; Kathy Crane; Della White; Susan Pav; Yong Wang; Ming-Hong Hao; Christine A. Grygon; Mark E. Labadia; Dorothy M. Freeman; Walter Davidson; Jerry L. Hopkins; Maryanne L. Brown; Denice M. Spero

Collaboration


Dive into the Daniel W. McNeil's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge